IFITM1, belonging to the IFN-induced transmembrane protein family, exhibits high expressions in tumor tissues and cells, and it is an independent prognostic biomarker for patients suffering from tumors including gallbladder carcinoma, esophageal adenocarcinoma, colorectal cancer, and gastric cancer (36). This evidence concerns the gene IFITM1 and gastric cancer.